↓ Skip to main content

Spanish guidelines for the management of autosomal dominant polycystic kidney disease *

Overview of attention for article published in Nephrology Dialysis Transplantation, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
12 X users
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
109 Mendeley
Title
Spanish guidelines for the management of autosomal dominant polycystic kidney disease *
Published in
Nephrology Dialysis Transplantation, August 2014
DOI 10.1093/ndt/gfu186
Pubmed ID
Authors

Elisabet Ars, Carmen Bernis, Gloria Fraga, Víctor Martínez, Judith Martins, Alberto Ortiz, José Carlos Rodríguez-Pérez, Laia Sans, Roser Torra, on behalf of the Spanish Working Group on Inherited Kidney Disease

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent cause of genetic renal disease and accounts for 6-10% of patients on renal replacement therapy (RRT). Very few prospective, randomized trials or clinical studies address the diagnosis and management of this relatively frequent disorder. No clinical guidelines are available to date. This is a consensus statement presenting the recommendations of the Spanish Working Group on Inherited Kidney Diseases, which were agreed to following a literature search and discussions. Levels of evidence found were C and D according to the Centre for Evidence-Based Medicine (University of Oxford). The recommendations relate to, among other topics, the use of imaging and genetic diagnosis, management of hypertension, pain, cyst infections and bleeding, extra-renal involvement including polycystic liver disease and cranial aneurysms, management of chronic kidney disease (CKD) and RRT and management of children with ADPKD. Recommendations on specific ADPKD therapies are not provided since no drug has regulatory approval for this indication.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 3 3%
United States 1 <1%
Unknown 105 96%

Demographic breakdown

Readers by professional status Count As %
Other 20 18%
Researcher 17 16%
Student > Bachelor 12 11%
Student > Postgraduate 9 8%
Student > Ph. D. Student 8 7%
Other 22 20%
Unknown 21 19%
Readers by discipline Count As %
Medicine and Dentistry 57 52%
Nursing and Health Professions 6 6%
Biochemistry, Genetics and Molecular Biology 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Agricultural and Biological Sciences 3 3%
Other 9 8%
Unknown 26 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2017.
All research outputs
#3,963,730
of 22,763,032 outputs
Outputs from Nephrology Dialysis Transplantation
#1,390
of 5,958 outputs
Outputs of similar age
#40,699
of 236,474 outputs
Outputs of similar age from Nephrology Dialysis Transplantation
#10
of 65 outputs
Altmetric has tracked 22,763,032 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,958 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,474 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.